Products for Research Use Only
RegisterLogin

PHD2/HDACs-IN-1

CAT: 0804-HY-144332Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-144332Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PHD2/HDACs-IN-1 is a potent PHD2/HDACs hybrid inhibitor (IC50s of 1.15 μM, 19.75 μM, 26.60 μM and 15.98 μM for PHD2, HDAC1, HDAC2 and HDAC6, respectively) . PHD2/HDACs-IN-1 is a low-toxicity renoprotective agent for research of cisplatin-induced acute kidney injury (AKI) [1].
CAS Number
2339867-53-5
UNSPSC
12352005
Target
HDAC; HIF/HIF Prolyl-Hydroxylase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/phd2-hdacs-in-1.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CN=C(N2CCC(NC(C3=CN=C(N4N=CC=C4)NC3=O)=O)CC2)N=C1)NO
Molecular Formula
C18H19N9O4
Molecular Weight
425.40
References & Citations
[1]Wei H, et al. Novel PHD2/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury. Eur J Med Chem. 2022;230:114115.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1; HDAC2; HDAC6

Related Products

CatalogName
HY-169405AAK1/HDACs-IN-1
HY-162349PARP7/HDACs-IN-1
HY-169400HDACs/EZH2-IN-1
HY-155009PHD2-IN-1
HY-114414-01HDACs/mTOR Inhibitor 1
HY-P5648PhD2
HY-176408PHD2-IN-5
HY-15692PHD2-IN-3
HY-177271PHD2-IN-6
HY-162438PHD2-IN-2

Alternative Products

CatalogName
T62298-01PHD2/HDACs-IN-1
T209440-01PARP7/HDACs-IN-1
GTR19240307-01HDACs/EZH2-IN-1
GTR19241334-01AAK1/HDACs-IN-1
MBS5753274HDACs/mTOR Inhibitor 1
A13462-100HDACs/mTOR Inhibitor 1 100mg
T79241-01PHD2-IN-1
A13462-50HDACs/mTOR Inhibitor 1 50mg
A13462-5HDACs/mTOR Inhibitor 1 5mg
A13462-25HDACs/mTOR Inhibitor 1 25mg

Popular Products